These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 20102720)
1. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720 [TBL] [Abstract][Full Text] [Related]
2. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
3. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer. Garre P; Martín L; Bando I; Tosar A; Llovet P; Sanz J; Romero A; de la Hoya M; Díaz-Rubio E; Caldés T Fam Cancer; 2014 Mar; 13(1):109-19. PubMed ID: 24061861 [TBL] [Abstract][Full Text] [Related]
4. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
7. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
9. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. Antelo M; Balaguer F; Shia J; Shen Y; Hur K; Moreira L; Cuatrecasas M; Bujanda L; Giraldez MD; Takahashi M; Cabanne A; Barugel ME; Arnold M; Roca EL; Andreu M; Castellvi-Bel S; Llor X; Jover R; Castells A; Boland CR; Goel A PLoS One; 2012; 7(9):e45357. PubMed ID: 23049789 [TBL] [Abstract][Full Text] [Related]
10. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families. Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866 [TBL] [Abstract][Full Text] [Related]
11. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118 [TBL] [Abstract][Full Text] [Related]
12. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298 [TBL] [Abstract][Full Text] [Related]
13. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469 [TBL] [Abstract][Full Text] [Related]
14. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619 [TBL] [Abstract][Full Text] [Related]
15. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer. Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055 [TBL] [Abstract][Full Text] [Related]
16. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912 [TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
19. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
20. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]